1. Home
  2. COEP vs AWRE Comparison

COEP vs AWRE Comparison

Compare COEP & AWRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • AWRE
  • Stock Information
  • Founded
  • COEP 2017
  • AWRE 1986
  • Country
  • COEP United States
  • AWRE United States
  • Employees
  • COEP N/A
  • AWRE N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • AWRE Computer Software: Prepackaged Software
  • Sector
  • COEP Health Care
  • AWRE Technology
  • Exchange
  • COEP Nasdaq
  • AWRE Nasdaq
  • Market Cap
  • COEP 32.4M
  • AWRE 35.2M
  • IPO Year
  • COEP N/A
  • AWRE 1996
  • Fundamental
  • Price
  • COEP $11.08
  • AWRE $1.68
  • Analyst Decision
  • COEP
  • AWRE
  • Analyst Count
  • COEP 0
  • AWRE 0
  • Target Price
  • COEP N/A
  • AWRE N/A
  • AVG Volume (30 Days)
  • COEP 190.1K
  • AWRE 37.7K
  • Earning Date
  • COEP 03-25-2025
  • AWRE 03-11-2025
  • Dividend Yield
  • COEP N/A
  • AWRE N/A
  • EPS Growth
  • COEP N/A
  • AWRE N/A
  • EPS
  • COEP N/A
  • AWRE N/A
  • Revenue
  • COEP N/A
  • AWRE $16,966,000.00
  • Revenue This Year
  • COEP N/A
  • AWRE $10.98
  • Revenue Next Year
  • COEP N/A
  • AWRE N/A
  • P/E Ratio
  • COEP N/A
  • AWRE N/A
  • Revenue Growth
  • COEP N/A
  • AWRE N/A
  • 52 Week Low
  • COEP $2.31
  • AWRE $1.35
  • 52 Week High
  • COEP $13.70
  • AWRE $2.97
  • Technical
  • Relative Strength Index (RSI)
  • COEP 56.43
  • AWRE 56.48
  • Support Level
  • COEP $8.65
  • AWRE $1.60
  • Resistance Level
  • COEP $13.70
  • AWRE $1.75
  • Average True Range (ATR)
  • COEP 1.96
  • AWRE 0.10
  • MACD
  • COEP -0.22
  • AWRE 0.01
  • Stochastic Oscillator
  • COEP 47.58
  • AWRE 86.36

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

Share on Social Networks: